Characterization of T-cells in Chronic lymphocytic leukemia and their modulation by clinically-approved targeted therapies with PI3Kdelta inhibitors

Ähnliche Einträge

• Simultaneous inhibition of PI3Kgamma and PI3Kdelta deteriorates t-cell function with implications for chronic lymphocytic leukemia
  von: Faehling, Sebastian, et al.
  Veröffentlicht: (2023)
• Characterizing and targeting the tumor microvironment in chronic lymphocytic leukemia
  von: Hanna, Bola
  Veröffentlicht: (2016)
• IGF1R as druggable target mediating PI3K-delta inhibitor resistance in a murine model of chronic lymphocytic leukemia
  von: Scheffold, Annika, et al.
  Veröffentlicht: (2019)
• High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies
  von: Dreger, Peter
  Veröffentlicht: (2018)
• Identification and characterization of genes deregulated by DNA methylation in chronic lymphocytic leukemia
  von: Filarsky, Katharina
  Veröffentlicht: (2015)